Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Super Micro Computer Inc (SMCI) Price & Performance

Heron Therapeutics IncTrade
Super Micro Computer IncTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Super Micro Computer Inc — how do they compare? Heron Therapeutics Inc trades at $0.35 (market cap $61.47M), while Super Micro Computer Inc trades at $37.18 (market cap $20.44B). The key difference: Super Micro Computer Inc is far larger — about 332.5× Heron Therapeutics Inc's market cap, and Super Micro Computer Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

HRTXSMCI
Market Cap
$61.47M$20.44B
Sector
HealthTechnology
52-Week High
$1.49$58.68
52-Week Low
$0.32$20.53
Enterprise Value
$168.21M$27.96B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.

The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.

Super Micro Computer Inc

Super Micro Computer (SMCI) trades at $36.75, up 16.85% on strong Q4 2026 earnings, beating EPS estimates with $1.70 actual versus $0.92 expected. The stock shows bullish technical signals with moving averages supporting upward momentum, while RSI indicates potential overbought conditions. Revenue surged 93% year-over-year to $11.1 billion in Q4, though slightly below the $11.6 billion consensus, with robust FY2027 guidance of $65–72 billion revenue highlighting AI-driven demand.

Outlook remains positive due to AI infrastructure growth and earnings beats, but risks include supply chain delays and high valuation multiples. Analysts maintain a $40.40 consensus target with 36% buy ratings. Investors should weigh strong cash flow and margin expansion against competitive pressures and macroeconomic volatility.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About Super Micro Computer Inc

Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.

Read more on SMCI